Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents.
about
Genetic variation in BCL2 3'-UTR was associated with lung cancer risk and prognosis in male Chinese populationPurine nucleoside analog--sulfinosine modulates diverse mechanisms of cancer progression in multi-drug resistant cancer cell linesProteomic analysis of apoptosis induction in human lung cancer cells by recombinant MVL.Investigation of the epidermal growth factor receptor mutation rate in non-small cell lung cancer patients and the analysis of associated risk factors using logistic regression.Sequential treatment of icotinib after first-line pemetrexed in advanced lung adenocarcinoma with unknown EGFR gene status.Long noncoding RNA expression profiles of lung adenocarcinoma ascertained by microarray analysis.Targeting HER1/EGFR in cancer therapy: experience with erlotinib.Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer.Crude alkaloid extract of Rhazya stricta inhibits cell growth and sensitizes human lung cancer cells to cisplatin through induction of apoptosis.C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer.Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer?LncRNA LINC01512 Promotes the Progression and Enhances Oncogenic Ability of Lung Adenocarcinoma.Low Expression LncRNA TUBA4B is a Poor Predictor of Prognosis and Regulates Cell Proliferation in Non-Small Cell Lung Cancer.Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis.Silencing of X-linked inhibitor of apoptosis decreases resistance to cisplatin and paclitaxel but not gemcitabine in non-small cell lung cancer.RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation.Growth-inhibitory effects of a Bulnesia sarmienti aqueous extract on A549 cells in vitro and S180 cells in vivo.Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis.Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer.k-RAS mutations in non-small cell lung cancer patients treated with TKIs among smokers and non-smokers: a meta-analysis.lncRNA LOC100132354 promotes angiogenesis through VEGFA/VEGFR2 signaling pathway in lung adenocarcinomaLong non-coding RNA, CHRF, predicts poor prognosis of lung adenocarcinoma and promotes cell proliferation and migration
P2860
Q28387362-EF2A8572-A4B7-49C7-843C-B4904C258AF4Q28484976-F520F46F-C6CC-4818-8504-BF430687DF22Q33744130-F1E2865D-8136-481F-8F15-D2A430E54CD0Q33844140-A5612B90-F61F-4D76-A3F6-C235D5076BB4Q33995172-79DD9E4F-AB36-4943-B4D4-8B5E2CFC8499Q34000067-0E050862-BAA2-4CEB-B37F-9BF75D8D764EQ36429516-6EB9A5C7-A80D-4055-8348-69F717530687Q36631504-196FEA04-3285-43C9-8FFE-93F0B31E301EQ36737444-1FE25457-D69E-4BE9-B024-71B8AD881D9EQ38347474-8B3933ED-BD2B-4309-B75A-8B1CCE1D0755Q38389980-582BBEFB-46FA-4709-B63D-F2DD4DA3DA2DQ38751455-924DE540-5F5F-4C4D-80E1-238F21E0A6A1Q38758341-DA541E83-DF86-4F6E-84CE-5F189F257054Q38917304-D8C41D1C-ED36-4084-A0A4-4D33A4E9062CQ39437240-2A36CAA4-C708-4EBD-9826-B3CEE9F5DEE1Q39590554-242C9659-2F48-4179-BBFD-05EBE82E8304Q39833299-3C93F075-BEAA-4F96-88DB-909456DE54A8Q40071923-FD2C21BA-0F11-4EEB-8204-3A4FDC464F15Q41902053-1AED5014-D83B-4E9F-9BAD-65AE6C67BD01Q42009257-55169FCC-9AB3-4D49-B2B3-3C318F9A703EQ57482786-19B736F4-94F1-433B-92EA-CD660DEE072EQ58573171-1FDB2154-161C-40A4-BFAA-EEBF60068C42
P2860
Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Treatment of non-small-cell lu ...... opment of new biologic agents.
@ast
Treatment of non-small-cell lu ...... opment of new biologic agents.
@en
type
label
Treatment of non-small-cell lu ...... opment of new biologic agents.
@ast
Treatment of non-small-cell lu ...... opment of new biologic agents.
@en
prefLabel
Treatment of non-small-cell lu ...... opment of new biologic agents.
@ast
Treatment of non-small-cell lu ...... opment of new biologic agents.
@en
P356
P1433
P1476
Treatment of non-small-cell lu ...... opment of new biologic agents.
@en
P2093
Antonio Rossi
Paolo Maione
P2888
P304
P356
10.1038/SJ.ONC.1206957
P407
P577
2003-09-01T00:00:00Z